ENERGIST ULTRA VPL INTENSE PULSE LIGHT SYSTEM

K060216 · Energist, Ltd. · GEX · Mar 16, 2006 · General, Plastic Surgery

Device Facts

• Record ID: K060216
• Device Name: ENERGIST ULTRA VPL INTENSE PULSE LIGHT SYSTEM
• Applicant: Energist, Ltd.
• Product Code: GEX · General, Plastic Surgery
• Decision Date: Mar 16, 2006
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4810
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Energist ULTRA™ VPL Intense Pulsed Light System is intended for permanent hair reduction and the treatment of mild to moderate inflammatory Acne Vulgaris. It is also indicated for photocoagulation of dermatological vascular lesions, photothermolysis of blood vessels and the treatment of benign pigmented lesions. The 530 - 950nm intense pulsed wavelengths are indicated for: The treatment of mild to moderate inflammatory Acne Vulgaris. The treatment of benign pigmented epidermal and cutaneous lesions including warts, scars and striae. The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea. melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins. facial veins and venous malformations. The 610 - 950nm intense pulsed wavelengths are indicated for: The removal of unwanted hair from all skin types and to effect stable longterm or permanent hair reduction in skin types I - V through selective targeting of melanin in hair follicles.

Device Story

Energist ULTRA VPL is a compact, self-contained intense pulsed light (IPL) system; delivers non-ionizing radiation via removable handpiece with integrated lamp, filter, and glass coupling block. System includes control console, display panel, power supply, and cooling system. Operates by emitting pulsed light at 530-950nm or 610-950nm wavelengths to target melanin in hair follicles or vascular/pigmented structures via photothermolysis/photocoagulation. Used in clinical settings by trained operators. Output allows clinicians to perform dermatological procedures; benefits include hair reduction and treatment of vascular/pigmented lesions and acne.

Clinical Evidence

Bench testing only. No clinical data provided. Performance data demonstrated the system provides necessary outputs to achieve required treatment parameters.

Technological Characteristics

IPL system; wavelengths 530-950nm and 610-950nm. Features control console, display, power supply, cooling system, and removable handpiece with integrated switch, lamp, filter, and glass coupling block. Software-controlled high-voltage component.

Indications for Use

Indicated for permanent hair reduction (skin types I-V) and treatment of mild-to-moderate inflammatory Acne Vulgaris. Also indicated for photocoagulation/photothermolysis of benign pigmented epidermal/cutaneous lesions (warts, scars, striae) and benign cutaneous vascular lesions (port wine stains, hemangiomas, telangiectasias, rosacea, melasma, angiomas, spider angiomas, poikiloderma of Civatte, leg/facial veins, venous malformations).

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

• McCue Energist ULTRA™ (K040659)
• Cyden IFL Professional System (K050165)

Submission Summary (Full Text)

{0}------------------------------------------------

# Section 5 - 510(k) Summary

This 510(k) summary of safety and effectiveness for the Energist ULTRA variable pulsed light system has been prepared in accordance with the requirements of the Safe Medical Device Act (SMDA) of 1990 and follows relevant Office of Device Evaluation (ODE) guidance concerning the organisation and content of a 510(k) summary.

### 5.1 Applicant

Energist Ltd

### 5.2 Address

2 Clos Llyn Cwm , Enterprise Park, Swansea SA6 8QY, UK

#### 5.3 Contact Person

Peter Smith, Engineering & Regulatory Affairs Manager Tel: [phone] Fax: [phone]

### 5.4 Preparation Date

January 19, 2006

#### 5.5 Device Trade Name

Energist ULTRA Variable Pulsed Light (VPL™) System

### 5.6 Device Common Name

Intense Pulsed Light System

#### 5.7 Device Classification

Laser surgical instrument for use in General and Plastic Surgery and Dermatology Product code: GEX 21 CFR 878.4810

#### 5.8 Legally marketed Predicate Devices

McCue Energist ULTRA™, K040659 Cyden IFL Professional System, K050165

#### 5.9 Device Description

The Energist ULTRA VPL™ System is a light based medical device that delivers a beam of pulsed non-ionising radiation in the region of 530nm. The system is designed to be compact and self contained and includes the following features:

- . Control console unit
- Display panel .
- Power supply ◆
- Cooling system .
- . Removable handpiece with integrated switch, lamp, filter and glass coupling block

#### 5.10 Intended Use

The Energist ULTRA™ VPL Intense Pulsed Light System is intended for permanent hair reduction and the treatment of mild to moderate inflammatory Acne Vulgaris. It is also indicated for photocoagulation of dermatological vascular lesions, photothermolysis of blood vessels and the treatment of benign pigmented lesions.

- . Intense Pulsed Light Energy / wavelengths (530 - 950nm)

{1}------------------------------------------------

The 530 - 950nm intense pulsed wavelengths are indicated for:

The treatment of mild to moderate inflammatory Acne Vulgaris.

The treatment of benign pigmented epidermal and cutaneous lesions including warts, scars and striae.

The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea. melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins, facial veins and venous malformations.

- Intense Pulsed Light Energy / wavelengths (610 950nm) .
The 610 - 950nm intense pulsed wavelengths are indicated for:

The removal of unwanted hair from all skin types and to effect stable longterm or permanent 1 hair reduction in skin types I - V through selective targeting of melanin in hair follicles.

1 Permanent hair reduction is defined as a long-term stable reduction in the number of hairs regrowing after a treatment regimen.

#### 5.11 Comparison of Technological Characteristics

The Energist ULTRA VPL System has an identical intended use to the McCue predicate system and identical technological characteristics except for modifications to the device software and high voltage component. These differences do not result in differences in performance or raise new questions of safety and efficacy. The Energist ULTRA VPL System also has the same principles of operation, mode of action and equivalent energy outputs that are used by the Cyden predicate device to achieve the treatment of Acne Vulgaris. Performance data was provided to demonstrate that the system is capable of providing the outputs necessary to achieve its required treatment parameters. The Energist ULTRA VPL ™ System is therefore concluded to be substantially equivalent to both of the above named predicate devices and minor differences to the systems do not raise additional concerns of safety and efficacy.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS). The seal features a stylized eagle with three lines forming its body and wings, facing right. The eagle is surrounded by a circular border containing the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" in capital letters.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR 16 2006

Energist, Ltd. c/o Mr. Peter Smith Engineering & Regulatory Affairs Manager 2 Clos Llyn Cwm Enterprise Park Swansea City and County of Swansea SA6 AQY United Kingdom

Re: K060216

Trade/Device Name: Energist ULTRA™ VPL Intense Pulse Light System Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: January 19, 2006 Received: January 27, 2006

Dear Mr. Smith:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must

{3}------------------------------------------------

## Page 2 - Mr. Peter Smith

comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your dryice to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Mark N. Melkerson Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

## Indications for Use

060216 510(k) Number (if known): A

Device Name: ___ Energist ULTRA™ VPL Intense Pulse Light System

Indications for Use:

The Energist ULTRA™ VPL Intense Pulsed Light System is intended for permanent hair reduction and the treatment of mild to moderate inflammatory Acne Vulgaris. It is also indicated for photocoagulation of dermatological vascular lesions, photothermolysis of blood vessels and the treatment of benign pigmented lesions.

- Intense Pulsed Light Energy / wavelengths (530 950nm) .
The 530 - 950nm intense pulsed wavelengths are indicated for:

The treatment of mild to moderate inflammatory Acne Vulgaris.

The treatment of benign pigmented epidermal and cutaneous lesions including warts, scars and striae.

The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea. melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins. facial veins and venous malformations.

Intense Pulsed Light Energy / wavelengths (610 - 950nm) .

The 610 - 950nm intense pulsed wavelengths are indicated for:

The removal of unwanted hair from all skin types and to effect stable longterm or permanent 1 hair reduction in skin types I - V through selective targeting of melanin in hair follicles.

1 Permanent hair reduction is defined as a long-term stable reduction in the number of hairs regrowing after a treatment regimen.

(Over)

Prescription Use × (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Image /page/4/Picture/19 description: This image shows a document with the title "Concurrence of CDRH, Office of Device Evaluation (ODE)". It also states "Division of General, Restorative, and Neurological Devices". The document includes the section number and page number, with "Section 4" and "Page 2" written at the bottom. The 510(k) number is K060216.